Literature DB >> 3304794

Poor correlation between the erythrocyte sedimentation rate and clinical activity in juvenile rheumatoid arthritis.

E H Giannini, E J Brewer.   

Abstract

Despite questions regarding its validity as an estimator of inflammatory disease activity, monitoring of the erythrocyte sedimentation rate (ESR) continues to be routine practice among pediatric rheumatologists caring for children with juvenile rheumatoid arthritis (JRA). We studied a large group of patients with JRA in order to determine the degree of correlation between clinically apparent inflammation and the ESR. regression and correlation analyses and descriptive statistical techniques were used to establish the relationship between 1) the ESR and the amount of clinically apparent inflammation at a point in time, and 2) changes in the ESR and the corresponding changes in apparent inflammation. One hundred fifty-nine children with JRA who were participants in a double-blind, controlled trial of two antirheumatic drugs were assessed for clinical and laboratory evidence of inflammatory disease activity at an initial visit, and then periodically for the duration of the one year study. Results showed that, at the initial assessment, neither the total number of joints with active arthritis nor the severity score correlated well with the ESR (r = .196 and .245 respectively). These findings were independent of the course type of JRA and age of the child. Changes from baseline in inflammation showed little correlation (r less than .25) with changes in the ESR. These findings suggest that the ESR is a relatively poor indicator of the amount of articular inflammation present, and that changes of disease activity are not reflected closely by changes in the ESR among children with JRA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304794     DOI: 10.1007/BF02201024

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation.

Authors:  E J Brewer; J Bass; J Baum; J T Cassidy; C Fink; J Jacobs; V Hanson; J E Levinson; J Schaller; J S Stillman
Journal:  Arthritis Rheum       Date:  1977-03

2.  Reference method for the erythrocyte sedimentation rate (ESR) test on human blood.

Authors: 
Journal:  Br J Haematol       Date:  1973-05       Impact factor: 6.998

3.  [Our experience with the Panchenkov (microsedimentation) test].

Authors:  F Tónay
Journal:  Orv Hetil       Date:  1971-06-20       Impact factor: 0.540

4.  [Elaboration of the criteria for the early diagnosis of juvenile rheumatoid arthritis (JRA)].

Authors:  A V Dolgopolova; V P Bisiarina; L S Alekseev; E S Lepskaia; N A Dmitrova
Journal:  Vopr Revm       Date:  1979 Oct-Dec

5.  Standard methodology for Segment I, II, and III Pediatric Rheumatology Collaborative Study Group studies. II. Analysis and presentation of data.

Authors:  E H Giannini; E J Brewer
Journal:  J Rheumatol       Date:  1982 Jan-Feb       Impact factor: 4.666

6.  Standard methodology for Segment I, II, and III Pediatric Rheumatology Collaborative Study Group studies. I. Design.

Authors:  E J Brewer; E H Giannini
Journal:  J Rheumatol       Date:  1982 Jan-Feb       Impact factor: 4.666

7.  Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial.

Authors:  E J Brewer; E H Giannini; N Kuzmina; L Alekseev
Journal:  N Engl J Med       Date:  1986-05-15       Impact factor: 91.245

  7 in total
  3 in total

Review 1.  Juvenile rheumatoid arthritis--assessment.

Authors:  T B Graham; E H Giannini
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Assessment of pain in patients with juvenile rheumatoid arthritis: relation between pain intensity and degree of joint inflammation.

Authors:  N T Ilowite; G A Walco; R Pochaczevsky
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

3.  High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.

Authors:  Mikel Alberdi-Saugstrup; Marek Zak; Susan Nielsen; Troels Herlin; Ellen Nordal; Lillemor Berntson; Anders Fasth; Marite Rygg
Journal:  Rheumatol Int       Date:  2017-03-10       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.